Eurofins Amatsigroup
Industriepark-Zwijnaarde 7B
9052 Gent
BE
Eurofins Amatsigroup
Foundation date
19/10/2007
Sector
#Biotechnology / R&D ServicesSubsector
- #R&D Services - Cell culture
- #R&D Services - CMO (Contract Manufacturing Organization)
- #R&D Services - CRO (Contract Research Organization)
- #R&D Services - Diagnostic services
- #R&D Services - Drug delivery
- #R&D Services - Fill & finish
Eurofins CDMO is a leading international & innovative CDMO and a one-stop-shop partner guiding you from (pre-)clinical development to clinical manufacturing & logistics.
Our expertise lies in drug substance development & manufacturing for biologics and drug product development & manufacturing for small molecules and biologics.
We specifically have a long-term record in handling complex proteins, producing live/inactivated vaccines, enhancing strategies for compounds with low solubility (highway to clinic) and colon-targeted formulations.
We can offer a broad range of dosage forms and manufacturing can be performed in a non-sterile or sterile way, always supported by a large portfolio of analytical methods.
Eurofins CDMO is a trusted partner, where innovation is key to help customers with their life-saving medicines.
Upcoming events
All events-
1010 '24
-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group -
1012 '24
Next-Generation Synthetic Biology
Event by: VIB
Latest news
More news-
Kurma Partners achieves first close of new EUR 250 million Biofund IV
Thursday October 3rd 2024
Read more
-
Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety
Tuesday October 1st 2024
Read more
-
Obulytix appoints Dr. Kristof Van Emelen as Chief Executive Officer
Tuesday October 1st 2024
Read more
Jobs by Eurofins Amatsigroup
More jobsMore info?
Ellen Telleir
Communication Coordinator